---
stable_id: R-HSA-8980691
display_name: RHOA GEFs activate RHOA
species: Homo sapiens
summary: 'The following guanine nucleotide exchange factors (GEFs) were shown to bind
  RHOA and catalyze GDP to GTP exchange on RHOA, resulting in formation of the active
  RHOA:GTP complex (the high throughput study by Bagci et al. 2020 looked at preferential
  binding of GEFs to nucleotide-free RHOA mutant compared to wild type RHOA but did
  not examine guanine nucleotide exchange):<br>AKAP13 (Zheng et al. 1995; Müller et
  al. 2020; supported by Bagci et al. 2020)<br>ARHGEF1 (Hart et al. 1996; Jaiswal
  et al. 2011; Jaiswal et al. 2013; Toffali et al. 2017; Müller et al. 2020; supported
  by Bagci et al. 2020)<br>ARHGEF2 (Krendel et al. 2002; Müller et al. 2020; supported
  by Bagci et al. 2020)<br>ARHGEF3 (Arthur et al. 2002; Sloan et al. 2012; Müller
  et al. 2020)<br>ARHGEF5 (Xie et al. 2005; Wang et al. 2009; supported by Bagci et
  al. 2020)<br>ARHGEF10 (Mohl et al. 2006; Aoki et al. 2009; Müller et al. 2020)<br>ARHGEF11
  (Rümenapp et al. 1999; Jaiswal et al. 2011; Jaiswal et al. 2013; Müller et al. 2020;
  supported by Bagci et al. 2020)<br>ARHGEF12 (Reuther et al. 2001; Jaiswal et al.
  2011; Jaiswal et al. 2013; Müller et al. 2020; supported by Bagci et al. 2020)<br>ARHGEF15
  (Fukushima et al. 2016; Müller et al. 2020)<br>ARHGEF17 (Rümenapp et al. 2002; Mitin
  et al. 2012; Müller et al. 2020; supported by Bagci et al. 2020)<br>ARHGEF19 (Wang
  et al. 2004; Müller et al. 2020)<br>ARHGEF25 (Sloan et al. 2012; Müller et al. 2020)<br>ARHGEF28
  (van Horck et al. 2001; Jaiswal et al. 2011; Jaiswal et al. 2013; Müller et al.
  2020)<br>ECT2 (Tatsumoto et al. 1999; Müller et al. 2020; supported by Bagci et
  al. 2020)<br>MCF2 (Sloan et al. 2012; Jaiswal et al. 2013; Müller et al. 2020)<br>NET1
  (Alberts and Treisman 1998; Müller et al. 2020)<br>NGEF (Zhang et al. 2007; Müller
  et al. 2020; supported by Bagci et al. 2020)<br>OBSCN (Ford Speelman et al. 2009)<br>PLEKHG5
  (de Toledo et al. 2001; Liu and Horowitz 2006; Müller et al. 2020)<br>PLEKHG6 (Müller
  et al. 2020)<br>RASGRF2 (Müller et al. 2020)<br>TRIO (TRIO and KALRN possess two
  GEF domains, the N-terminal GEF1 and the C-terminal GEF2; Debant et al. 1996 demonstrated
  activation of RHOA by the C-terminal GEF2 domain of TRIO, while Peurois et al. 2017
  demonstrated activation of RHOA by the N-terminal GEF1 domain of TRIO in the presence
  of membranes, Williams et al. 2007 showed that in C-elegans GNAQ-mediated activation
  of TRIO results in RHOA activation that drived locomotion and egg laying, and Bagci
  et al. 2020 reported binding of inactive RHOA mutant to the full-length TRIO; Debant
  et al. 1996 and Jaiswal et al. 2013 showed that the N-terminal GEF1 domain of TRIO
  does not activate RHOA; Müller et al. 2020 detected no activation of RHOA in the
  presence of full-length TRIO, but in this study HEK293 cells were used, which were
  previously shown by Williams et al. 2007 to have a low TRIO-activation ability downstream
  of GNAQ)<br>VAV1 (Heo et al. 2005; Müller et al. 2020)<br>VAV2 (Heo et al. 2005;
  Sloan et al. 2012; Schuebel et al. 1998; Jaiswal et al. 2013; Müller et al. 2020;
  supported by Bagci et al. 2020)<br>VAV3 (Movilla and Bustelo 1999, Sachdev et al.
  2002; Müller et al. 2020)<br>They are annotated as RHOA GEF set members.<br><br>The
  following GEFs were shown to bind and activate RHOA in some but not all studies,
  or have not been sufficiently studied, and are annotated as candidate RHOA GEFs:<br>ABR
  (Chuang et al. 1995, Manser et al. 1998: activation of RHOA; Müller et al. 2020:
  no activation of RHOA)<br>ARHGEF4 (Müller et al. 2020: activation of RHOA; Gotthardt
  and Ahmadian 2007, Anderson and Hamann 2012, Jaiswal et al. 2013: no activation
  of RHOA)<br>ARHGEF7 (Manser et al. 1998: activation of RHOA; Jones and Katan 2007,
  Müller et al. 2020: no activation of RHOA; Bagci et al. 2020: no binding to RHOA)<br>ARHGEF10L
  (Winkler et al. 2005: activation of RHOA; Müller et al. 2020: no activation of RHOA)<br>ARHGEF18
  (Niu et al. 2003, Blomquist et al. 2000: activation of RHOA; Müller et al. 2020:
  no activation of RHOA)<br>ARHGEF40 (Curtis et al. 2004: activation of RHOA; Müller
  et al. 2020: no activation of RHOA; Bagci et al. 2020: no binding to RHOA)<br>BCR
  (Chuang et al. 1995: activation of RHOA; Bagci et al. 2020: binding to RHOA; Müller
  et al. 2020: no activation of RHOA)<br>DEF6 (Mavrakis et al. 2004: probable GEF,
  in vitro GEF activity not tested)<br>DOCK2 (Toffali et al. 2017: inconclusive; Müller
  et al. 2020: no activation of RHOA)<br>FARP1 (Koyano et al. 2001: activation of
  RHOA; Müller et al. 2020: no activation of RHOA; Bagci et al. 2020: inconclusive
  binding to RHOA)<br>KALRN (Penzes et al. 2001: the C-terminal GEF2 domain of KALRN
  binds RHOA and activates it, although activation was not demonstrated in vitro,
  while the N-terminal GEF1 domain of KALRN does not bind to RHOA; Wu et al. 2013:
  no effect on RHOA activity in mice with heterozygous Kalrn gene knockout; Müller
  et al. 2020: no activation of RHOA by full-length KALRN)<br>MCF2L (Whitehead et
  al. 1999, Sloan et al. 2012, Jaiswal et al. 2013, Müller et al. 2020: activation
  of RHOA; Bagci et al. 2020: no binding to RHOA)<br>PLEKHG3 (Bagci et al. 2020: binding
  to RHOA, RHOA activation not tested; Müller et al. 2020: no activation of RHOA)<br>PLEKHG4
  (Gupta et al. 2013: activation of RHOA; Müller et al. 2020: no activation of RHOA;
  Bagci et al. 2020: no binding to RHOA)<br>PREX1 (Jaiswal et al. 2013: activation
  of RHOA; Marei et al. 2016, Müller et al. 2020: no activation of RHOA) <br>PREX2
  (Müller et al. 2020: activation of RHOA; Joseph and Norris 2005: no activation of
  RHOA)<br>TIAM1 (Michiels et al. 1995: activation of RHOA; Jaiswal et al. 2013, Müller
  et al. 2020: no activation of RHOA; Bagci et al. 2020: no binding to RHOA)<br><br>The
  following GEFs do not act on RHOA or have been reported to not bind to RHOA, as
  indicated, without testing for activity: <br>ALS2 (Müller et al. 2020)<br>ARHGEF6
  (Ramakers et al. 2012; Müller et al. 2020)<br>ARHGEF9 (Reid et al. 1999; Jaiswal
  et al. 2013; Müller et al. 2020)<br>ARHGEF16 (Hiramoto Yamaki et al. 2010; Müller
  et al. 2020; no binding to RHOA by Bagci et al. 2020)<br>ARHGEF26 (Ellerbroek et
  al. 2004; Müller et al. 2020; no binding to RHOA by Bagci et al. 2020)<br>ARHGEF39
  (Müller et al. 2020)<br>DNMBP (Jaiswal et al. 2013; Müller et al. 2020; no binding
  to RHOA by Bagci et al. 2020)<br>DOCK1 (Côté and Vuori 2002; Müller et al. 2020;
  no binding to RHOA by Bagci et al. 2020)<br>DOCK3 (Müller et al. 2020)<br>DOCK4
  (Müller et al. 2020; no binding to RHOA by Bagci et al. 2020)<br>DOCK5 (Müller et
  al. 2020; no binding to RHOA by Bagci et al. 2020)<br>DOCK6 (Müller et al. 2020;
  no binding to RHOA by Bagci et al. 2020)<br>DOCK7 (Müller et al. 2020; no binding
  to RHOA byBagci et al. 2020)<br>DOCK8 (Müller et al. 2020; no binding to RHOA by
  Bagci et al. 2020)<br>DOCK9 (Ruiz Lafuente et al. 2015; Müller et al. 2020; no binding
  to RHOA by Bagci et al. 2020)<br>DOCK10 (Ruiz Lafuente et al. 2015; Müller et al.
  2020; no binding to RHOA by Bagci et al. 2020)<br>DOCK11 (Ruiz Lafuente et al. 2015;
  Müller et al. 2020; no binding to RHOA by Bagci et al. 2020)<br>ECT2L (Müller et
  al. 2020)<br>FARP2 (Kubo et al. 2002; Müller et al. 2020);<br>FGD1 (Olson et al.
  1996; Müller et al. 2020)<br>FGD2 (Huber et al. 2008; Müller et al. 2020)<br>FGD3
  (Müller et al. 2020)<br>FGD5 (Müller et al. 2020)<br>FGD6 (Müller et al. 2020)<br>FGD4
  (Umikawa et al. 1999; Müller et al. 2020)<br>GNA13 (Teo et al. 2016)<br>ITSN1 (Hussain
  et al. 2001; Jaiswal et al. 2013; Müller et al. 2020)<br>ITSN2 (Müller et al. 2020)<br>MCF2L2
  (Müller et al. 2020)<br>PLEKHG1 (Abiko et al. 2015; Müller et al. 2020; no binding
  to RHOA by Bagci et al. 2020)<br>PLEKHG2 (Ueda et al. 2008; Müller et al. 2020;
  no binding to RHOA by Bagci et al. 2020)<br>PLEKHG4B (Müller et al. 2020)<br>SOS1
  (Nimnual et al. 1998; Müller et al. 2020)<br>SOS2 (Nimnual et al. 1998; Müller et
  al. 2020)<br>SPATA13 (Hamann et al. 2007; Kawasaki et al. 2007; Bristow et al. 2009;
  Müller et al. 2020)<br>SWAP70 (Ocana Morgner et al. 2009; no binding to RHOA by
  Bagci et al. 2020)<br>TIAM2 (Müller et al. 2020)'
---

# RHOA GEFs activate RHOA
**Reactome ID:** [R-HSA-8980691](https://reactome.org/content/detail/R-HSA-8980691)
**Species:** Homo sapiens

## Summary

The following guanine nucleotide exchange factors (GEFs) were shown to bind RHOA and catalyze GDP to GTP exchange on RHOA, resulting in formation of the active RHOA:GTP complex (the high throughput study by Bagci et al. 2020 looked at preferential binding of GEFs to nucleotide-free RHOA mutant compared to wild type RHOA but did not examine guanine nucleotide exchange):<br>AKAP13 (Zheng et al. 1995; Müller et al. 2020; supported by Bagci et al. 2020)<br>ARHGEF1 (Hart et al. 1996; Jaiswal et al. 2011; Jaiswal et al. 2013; Toffali et al. 2017; Müller et al. 2020; supported by Bagci et al. 2020)<br>ARHGEF2 (Krendel et al. 2002; Müller et al. 2020; supported by Bagci et al. 2020)<br>ARHGEF3 (Arthur et al. 2002; Sloan et al. 2012; Müller et al. 2020)<br>ARHGEF5 (Xie et al. 2005; Wang et al. 2009; supported by Bagci et al. 2020)<br>ARHGEF10 (Mohl et al. 2006; Aoki et al. 2009; Müller et al. 2020)<br>ARHGEF11 (Rümenapp et al. 1999; Jaiswal et al. 2011; Jaiswal et al. 2013; Müller et al. 2020; supported by Bagci et al. 2020)<br>ARHGEF12 (Reuther et al. 2001; Jaiswal et al. 2011; Jaiswal et al. 2013; Müller et al. 2020; supported by Bagci et al. 2020)<br>ARHGEF15 (Fukushima et al. 2016; Müller et al. 2020)<br>ARHGEF17 (Rümenapp et al. 2002; Mitin et al. 2012; Müller et al. 2020; supported by Bagci et al. 2020)<br>ARHGEF19 (Wang et al. 2004; Müller et al. 2020)<br>ARHGEF25 (Sloan et al. 2012; Müller et al. 2020)<br>ARHGEF28 (van Horck et al. 2001; Jaiswal et al. 2011; Jaiswal et al. 2013; Müller et al. 2020)<br>ECT2 (Tatsumoto et al. 1999; Müller et al. 2020; supported by Bagci et al. 2020)<br>MCF2 (Sloan et al. 2012; Jaiswal et al. 2013; Müller et al. 2020)<br>NET1 (Alberts and Treisman 1998; Müller et al. 2020)<br>NGEF (Zhang et al. 2007; Müller et al. 2020; supported by Bagci et al. 2020)<br>OBSCN (Ford Speelman et al. 2009)<br>PLEKHG5 (de Toledo et al. 2001; Liu and Horowitz 2006; Müller et al. 2020)<br>PLEKHG6 (Müller et al. 2020)<br>RASGRF2 (Müller et al. 2020)<br>TRIO (TRIO and KALRN possess two GEF domains, the N-terminal GEF1 and the C-terminal GEF2; Debant et al. 1996 demonstrated activation of RHOA by the C-terminal GEF2 domain of TRIO, while Peurois et al. 2017 demonstrated activation of RHOA by the N-terminal GEF1 domain of TRIO in the presence of membranes, Williams et al. 2007 showed that in C-elegans GNAQ-mediated activation of TRIO results in RHOA activation that drived locomotion and egg laying, and Bagci et al. 2020 reported binding of inactive RHOA mutant to the full-length TRIO; Debant et al. 1996 and Jaiswal et al. 2013 showed that the N-terminal GEF1 domain of TRIO does not activate RHOA; Müller et al. 2020 detected no activation of RHOA in the presence of full-length TRIO, but in this study HEK293 cells were used, which were previously shown by Williams et al. 2007 to have a low TRIO-activation ability downstream of GNAQ)<br>VAV1 (Heo et al. 2005; Müller et al. 2020)<br>VAV2 (Heo et al. 2005; Sloan et al. 2012; Schuebel et al. 1998; Jaiswal et al. 2013; Müller et al. 2020; supported by Bagci et al. 2020)<br>VAV3 (Movilla and Bustelo 1999, Sachdev et al. 2002; Müller et al. 2020)<br>They are annotated as RHOA GEF set members.<br><br>The following GEFs were shown to bind and activate RHOA in some but not all studies, or have not been sufficiently studied, and are annotated as candidate RHOA GEFs:<br>ABR (Chuang et al. 1995, Manser et al. 1998: activation of RHOA; Müller et al. 2020: no activation of RHOA)<br>ARHGEF4 (Müller et al. 2020: activation of RHOA; Gotthardt and Ahmadian 2007, Anderson and Hamann 2012, Jaiswal et al. 2013: no activation of RHOA)<br>ARHGEF7 (Manser et al. 1998: activation of RHOA; Jones and Katan 2007, Müller et al. 2020: no activation of RHOA; Bagci et al. 2020: no binding to RHOA)<br>ARHGEF10L (Winkler et al. 2005: activation of RHOA; Müller et al. 2020: no activation of RHOA)<br>ARHGEF18 (Niu et al. 2003, Blomquist et al. 2000: activation of RHOA; Müller et al. 2020: no activation of RHOA)<br>ARHGEF40 (Curtis et al. 2004: activation of RHOA; Müller et al. 2020: no activation of RHOA; Bagci et al. 2020: no binding to RHOA)<br>BCR (Chuang et al. 1995: activation of RHOA; Bagci et al. 2020: binding to RHOA; Müller et al. 2020: no activation of RHOA)<br>DEF6 (Mavrakis et al. 2004: probable GEF, in vitro GEF activity not tested)<br>DOCK2 (Toffali et al. 2017: inconclusive; Müller et al. 2020: no activation of RHOA)<br>FARP1 (Koyano et al. 2001: activation of RHOA; Müller et al. 2020: no activation of RHOA; Bagci et al. 2020: inconclusive binding to RHOA)<br>KALRN (Penzes et al. 2001: the C-terminal GEF2 domain of KALRN binds RHOA and activates it, although activation was not demonstrated in vitro, while the N-terminal GEF1 domain of KALRN does not bind to RHOA; Wu et al. 2013: no effect on RHOA activity in mice with heterozygous Kalrn gene knockout; Müller et al. 2020: no activation of RHOA by full-length KALRN)<br>MCF2L (Whitehead et al. 1999, Sloan et al. 2012, Jaiswal et al. 2013, Müller et al. 2020: activation of RHOA; Bagci et al. 2020: no binding to RHOA)<br>PLEKHG3 (Bagci et al. 2020: binding to RHOA, RHOA activation not tested; Müller et al. 2020: no activation of RHOA)<br>PLEKHG4 (Gupta et al. 2013: activation of RHOA; Müller et al. 2020: no activation of RHOA; Bagci et al. 2020: no binding to RHOA)<br>PREX1 (Jaiswal et al. 2013: activation of RHOA; Marei et al. 2016, Müller et al. 2020: no activation of RHOA) <br>PREX2 (Müller et al. 2020: activation of RHOA; Joseph and Norris 2005: no activation of RHOA)<br>TIAM1 (Michiels et al. 1995: activation of RHOA; Jaiswal et al. 2013, Müller et al. 2020: no activation of RHOA; Bagci et al. 2020: no binding to RHOA)<br><br>The following GEFs do not act on RHOA or have been reported to not bind to RHOA, as indicated, without testing for activity: <br>ALS2 (Müller et al. 2020)<br>ARHGEF6 (Ramakers et al. 2012; Müller et al. 2020)<br>ARHGEF9 (Reid et al. 1999; Jaiswal et al. 2013; Müller et al. 2020)<br>ARHGEF16 (Hiramoto Yamaki et al. 2010; Müller et al. 2020; no binding to RHOA by Bagci et al. 2020)<br>ARHGEF26 (Ellerbroek et al. 2004; Müller et al. 2020; no binding to RHOA by Bagci et al. 2020)<br>ARHGEF39 (Müller et al. 2020)<br>DNMBP (Jaiswal et al. 2013; Müller et al. 2020; no binding to RHOA by Bagci et al. 2020)<br>DOCK1 (Côté and Vuori 2002; Müller et al. 2020; no binding to RHOA by Bagci et al. 2020)<br>DOCK3 (Müller et al. 2020)<br>DOCK4 (Müller et al. 2020; no binding to RHOA by Bagci et al. 2020)<br>DOCK5 (Müller et al. 2020; no binding to RHOA by Bagci et al. 2020)<br>DOCK6 (Müller et al. 2020; no binding to RHOA by Bagci et al. 2020)<br>DOCK7 (Müller et al. 2020; no binding to RHOA byBagci et al. 2020)<br>DOCK8 (Müller et al. 2020; no binding to RHOA by Bagci et al. 2020)<br>DOCK9 (Ruiz Lafuente et al. 2015; Müller et al. 2020; no binding to RHOA by Bagci et al. 2020)<br>DOCK10 (Ruiz Lafuente et al. 2015; Müller et al. 2020; no binding to RHOA by Bagci et al. 2020)<br>DOCK11 (Ruiz Lafuente et al. 2015; Müller et al. 2020; no binding to RHOA by Bagci et al. 2020)<br>ECT2L (Müller et al. 2020)<br>FARP2 (Kubo et al. 2002; Müller et al. 2020);<br>FGD1 (Olson et al. 1996; Müller et al. 2020)<br>FGD2 (Huber et al. 2008; Müller et al. 2020)<br>FGD3 (Müller et al. 2020)<br>FGD5 (Müller et al. 2020)<br>FGD6 (Müller et al. 2020)<br>FGD4 (Umikawa et al. 1999; Müller et al. 2020)<br>GNA13 (Teo et al. 2016)<br>ITSN1 (Hussain et al. 2001; Jaiswal et al. 2013; Müller et al. 2020)<br>ITSN2 (Müller et al. 2020)<br>MCF2L2 (Müller et al. 2020)<br>PLEKHG1 (Abiko et al. 2015; Müller et al. 2020; no binding to RHOA by Bagci et al. 2020)<br>PLEKHG2 (Ueda et al. 2008; Müller et al. 2020; no binding to RHOA by Bagci et al. 2020)<br>PLEKHG4B (Müller et al. 2020)<br>SOS1 (Nimnual et al. 1998; Müller et al. 2020)<br>SOS2 (Nimnual et al. 1998; Müller et al. 2020)<br>SPATA13 (Hamann et al. 2007; Kawasaki et al. 2007; Bristow et al. 2009; Müller et al. 2020)<br>SWAP70 (Ocana Morgner et al. 2009; no binding to RHOA by Bagci et al. 2020)<br>TIAM2 (Müller et al. 2020)
